|
|
|
|
|
|
|
|
|
|
|
|
Beneficial Owner of Shares of Common Stock(1)(2) |
|
Number of Shares
of Common Stock Beneficially Owned |
|
|
Percent of
Total Shares of
Common Stock
|
|
5%
Stockholders: |
|
|
|
|
|
|
|
|
The Vanguard Group, Inc. (3) |
|
|
17,042,500 |
|
|
|
6.2 |
% |
Directors and Named Executive
Officers: |
|
|
|
|
|
|
|
|
Jacqueline E. Shea, Ph.D.(4) |
|
|
881,788 |
|
|
|
|
* |
Simon X. Benito(5) |
|
|
227,605 |
|
|
|
|
* |
Roger D. Dansey, M.D.(6) |
|
|
111,500 |
|
|
|
|
* |
Ann C. Miller, M.D.(7) |
|
|
167,334 |
|
|
|
|
* |
Jay P. Shepard(8) |
|
|
146,821 |
|
|
|
|
* |
David B. Weiner, Ph.D.(9) |
|
|
1,543,424 |
|
|
|
|
* |
Wendy L. Yarno(10) |
|
|
187,453 |
|
|
|
|
* |
Lota S. Zoth(11) |
|
|
153,516 |
|
|
|
|
* |
Peter D. Kies(12) |
|
|
1,003,524 |
|
|
|
|
* |
Laurent M. Humeau, Ph.D.(13) |
|
|
718,962 |
|
|
|
|
* |
Michael Sumner(14) |
|
|
143,125 |
|
|
|
|
* |
All current executive officers
and directors as a group (12 persons)(15) |
|
|
5,285,052 |
|
|
|
1.9 |
|
J. Joseph Kim, Ph.D. (16) |
|
|
4,451,255 |
|
|
|
1.6 |
|
* Less than 1%.
(1) This table is based upon information supplied by officers, directors and principal stockholders. Except as otherwise noted below, the
address of each stockholder listed is in care of our principal executive offices at 660 W. Germantown Pike, Suite 110, Plymouth Meeting, Pennsylvania 19462.
(2) Except as otherwise indicated in the footnotes of this table and pursuant to applicable community property laws, the persons named in
the table have sole voting and investment power with respect to all shares of common stock. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or dispositive power with respect to securities.
Applicable percentages are based on 272,986,424 shares of common stock outstanding on November 16, 2023, adjusted as required by rules promulgated by the SEC.
(3) This information has been obtained from a Schedule 13G/A filed on February 9, 2023 by The Vanguard Group, Inc. The principal
business address of The Vanguard Group, Inc. is 100 Vanguard Blvd. Malvern, PA 19355. The Vanguard Group, Inc. and affiliated persons reported shared voting power with respect to 155,931 shares of common stock and shared dispositive power with
respect to 351,918 shares of common stock in addition to sole dispositive power with respect to 16,690,582 shares of common stock.
(4) Includes 683,675 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023.
(5) Includes 133,300 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023.
(6) Includes 68,500 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023.
(7) Includes 100,800 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023.
(8) Includes 88,300 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023.
(9) Includes 614,300 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023.
(10) Includes 113,300 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023.
(11) Includes 100,800 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023.
(12) Includes 762,025 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023. Also includes 4,500 shares held by Mr. Kiess spouse.
(13) Includes 504,325 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023.
(14) Includes 108,125 shares of common stock issuable pursuant to options exercisable within 60 days of November 16,
2023.
(15) Includes 3,277,450 shares of common stock issuable pursuant to options exercisable within 60 days of
November 16, 2023.
(16) This information has been obtained from a Form 4 filed by Dr. Kim on March 14, 2022,
which was the last report filed by Dr. Kim prior to his separation in May 2022. The reported amount includes (a) 816,527 shares held by a family limited partnership over which Dr. Kim held voting and dispositive power, (b) 5,975 shares
held by Dr. Kims spouse and (c) 100,871 shares held by Dr. Kims children. The reported amount also includes (d) 256,255 shares issued to Dr. Kim upon net settlement of RSUs in connection with his separation from our
company and (e) 1,849,000 shares of common stock issuable pursuant to options exercisable within 60 days of November 16, 2023.
18